about
A neurophysiological study of facial numbness in multiple sclerosis: Integration with clinical data and imaging findings.Body Mass Index in Multiple Sclerosis: Associations with CSF Neurotransmitter Metabolite LevelsRelapsing remitting multiple sclerosis in x-linked charcot-marie-tooth disease with central nervous system involvement.From mild ataxia to huntington disease phenocopy: the multiple faces of spinocerebellar ataxia 17.Friedreich's ataxia and other hereditary ataxias in Greece: an 18-year perspective.Late-onset Huntington's disease: diagnostic and prognostic considerations.Screening for the C9ORF72 repeat expansion in a greek frontotemporal dementia cohort.Psychosis as presenting symptom in adult-onset Hallervorden-Spatz syndrome.Ocular flutter as presenting manifestation of pediatric MOG antibody-associated demyelination: A case reportA case of Alemtuzumab-induced neutropenia in multiple sclerosis in association with the expansion of large granular lymphocytesReplication study of GWAS risk loci in Greek multiple sclerosis patientsTREM2 R47H (rs75932628) variant is unlikely to contribute to Multiple Sclerosis susceptibility and severity in a large Greek MS cohortScreening for spinocerebellar ataxia type 36 (SCA36) in the Greek populationResponse to correspondence: Testing for myelin oligodendrocyte glycoprotein antibody (MOG-IgG) in typical MSRecurrent myelitis and asymptomatic hypophysitis in IgG4-related disease: case-based reviewMOG antibody-associated demyelinating disease mimicking typical multiple sclerosis: A case for expanding anti-MOG testing?Evidence for Cognitive Deficits in X-Linked Charcot-Marie-Tooth DiseaseDeciphering anti-MOG IgG antibodies: Clinical and radiological spectrum, and comparison of antibody detection assays
P50
Q31131720-468BB277-12F8-4391-837B-BA6B173EDE2FQ37239636-67C8E9B1-F7A6-48DE-A17A-31FC181903BEQ39404453-1A08836E-E5D0-4439-8126-533BDE87808BQ42093755-DA2EF1F5-D55B-4D49-B61A-F73735C1CEE0Q44034652-EA83774F-3037-4F3E-BE3D-5A41627F7890Q45298748-1EFA0E9F-514D-4126-80AF-BC93A387B60FQ47427430-83E0FF11-DB82-424F-A1B5-6CC486E0588FQ48223210-A665F0C6-DAD1-4BF3-B531-51B0E4A94666Q58090081-3B62FF92-0B38-420D-AF87-66E9DD073A7EQ58101281-22577874-3C44-4ABE-B9D5-FEBA08C5C3F3Q58547359-9689B8CE-55E5-4607-A5E0-05F8963FA13CQ92288994-7C5FAE52-654F-43FD-BF26-4DEF0ABD63F5Q92317690-53D91B9C-240E-4EF1-896B-FA5A4057C3D8Q92383577-E56C2BB0-042E-4990-9C5C-270AE45A6562Q92394469-70994798-B0A7-4C6E-8BCD-A4F946284FA9Q92491423-ADFD79E3-2D18-4973-B81C-EB0D60945412Q92708157-E9253FAB-821B-4019-8753-1663860F0E7CQ92746118-0D773CBE-9DE3-485D-A4E1-F4B5CE55BE68
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Georgios Koutsis
@en
Georgios Koutsis
@nl
type
label
Georgios Koutsis
@en
Georgios Koutsis
@nl
prefLabel
Georgios Koutsis
@en
Georgios Koutsis
@nl
P31
P496
0000-0002-8980-8377